RE: RE: RE:18 Oct 2018 15:01
Zen,
Traumakine definiteyl works on as ection of the sub group.The wuestion si the bio markers generating uexpected results in last trial Marku said in his recent interview at no point did he not believe, which is a very very strong statement. What we are looking for is clarity and a solution to recent results. That in conjunction with route to market, and its a massive re-rate. The cash position is stable and there seems to be no desire to raise further cash, which could be a clue to news on Monday...